• Kleos has released its new geospatial intelligence product to initial customers
  • DC2 branches out from data centres with Attained acquisition
  • Radiopharm scrores US FDA approval for its αVβ6 Integrin technology for pancreatic cancer

 

Space tech company Kleos Space (ASX:KSS) says radio frequency (RF) data collected from the Vigilance Mission (KSF1) satellites has been successfully processed through the its technology platform generating the geospatial intelligence product (LOCATE) – which has now been released to initial customers.

The platform uses signal processing techniques to convert the raw data collected from sensors onboard Kleos’ RF data collection satellite constellation that is designed to collect and downlink RF data accurately and into actionable intelligence. 

LOCATE provides a valuable intelligence, surveillance, and reconnaissance (ISR) capability to governments and commercial entities, complementing other intelligence sources to improve the detection of illegal and/or hidden activity such as piracy, drug, and people smuggling, illegal fishing, pollution, and border challenges. 

“Our geospatial intelligence is now available to initial customers, with additional data volumes being made available as we bring more of our satellite constellation online,” CEO Andy Bowyer said. 

“Our technology delivers actionable intelligence from sensor collections, helping solve some of the world’s greatest societal, economic, and environmental challenges.” 

Plus, the company says recent advancements in its ground signal processing technology now allow the company to deliver the LOCATE geospatial intelligence product with as few as two satellites in a formation (a reduction from the previous minimum of three).

Along with algorithim advancements which allow the platform to ingest raw data from other non-Kleos sensors, this would potentially accelerate  the volume of intelligence available to customers with the possibility of lower CAPEX spending. 

 

KSS share price today:

 

Other tech stocks with notable news:

DC TWO (ASX:DC2)

Data centre company DC2 has expanded its offering, with the acquisition of IT cloud services provider Attained Group for ~$2 million in cash and shares.

It’s a strategic move to leverage the IT infrastructure foundations built over the last three years at the company’s flagship Bibra Lake data centre and will add “strong revenue and profit foundation” to accelerate the company’s move into the broader cloud microservices IT sector. 

According to Allied Market Research, the sector is globally projected to reach US$8 billion by 2026.

The acquisition covering several technology layers, deemed critical to build an end-to-end market offering, including cyber security, managed IT services, cloud services and network and voice solutions.

Attained will enable the company to expand its commercial footprint within Australia and other expanding markets it operates in, with a number of ASX listed and private clients who operate across Australia, UK, Asia and Europe. 

 

VISTA GROUP (ASX:VGL) 

Software stock Vista Group has signed a trade agreement with Cineworld Group as part of Cineworld’s chapter 11 process after it filed for bankruptcy in September in the US.

Under the trade agreement Cineworld Group has agreed to pay certain pre-chapter 11 amounts owing to Vista, and committed to continue to use the software and services of Vista Group’s companies under the terms of its existing agreements.

“Vista Group and Cineworld have a strong partnership developed over a number of years. We are pleased that Cineworld has committed to the partnership continuing on its current terms into the future,” Vista CEO Kimbal Riley said.

Vista has also updated its revenue guidance for FY2022 to between $131 million – $135 million (up from $123 million – 128 million) as a result of good recurring and non-recurring revenue performance, favourable foreign exchange movements, recent improvements in the collection of aged receivables, and, in connection with the trade agreement, the release of provisions in respect of amounts owed by Cineworld. 

 

AUDIO PIXELS (ASX:AKP)

The digital speaker developer says its $10m placement is still pending, after delays in approvals to remit funds from Chinese company Earth Mountain (Suzhou) Microelectronics Ltd (Earth Mountain) who committed to take 308,325 ordinary shares ($4,316,550). 

“The placement funds of US$3m have still not been received by 30 December 2022 and Earth Mountain has formally advised that the approval process is still underway with the approval applications lodged, however the COVID situation in China has been delaying the process and it may take several more months to finalise,” the company says.

AKP will advise the market as soon as the funds are received and the shares issued and in any case by 31 January 2023 in its Quarterly cash report. 

In view of the delay in getting the approvals for the US$3m from Earth Mountain, the directors decided it was prudent to place a further 105,476 ordinary shares at A$14.00 per share raising an additional A$1,476,669 (US$1m) from an existing overseas shareholder. 

 

DC2, VGL and AKP share prices today:

 

Health stocks with news today:

RADIOPHARM THERANOSTICS (ASX:RAD)

The diagnostic company has received US Food and Drug Administration (FDA) Investigational New Drug Application (IND) approval for its αVβ6 Integrin (RAD301) technology. 

The approval allows Radiopharm to begin a Phase 1 imaging trial in ambulatory patients with pancreatic cancer, targeting commencement at the end of Q1 CY23 with an estimated close by Q3 CY23. 

“We’re looking forward to working further with this peptide to prove its ability to deliver high quality imaging results in diagnosing pancreatic cancer,” CEO and MD Riccardo Canevari said.

“We’re very confident we can drive the speed of recruitment for the trial and that the technology will generate a positive outcome we can push toward commercialisation.”

The company is now proceeding with clinical site preparation for the trial, with the first subject expected to be dosed at Montefiore Einstein Cancer Center (MECC) in New York. 

 

WELLFULLY (ASX:WFL)

Wellfully has engaged Deutsche Gesellschaft für Wertpapieranalyse GmbH (DGWA) to act as its European investor relations partner for a minimum period of 12 months – with the goal of assisting the company to dual list on the Frankfurt Stock Exchange.

DGWA is a boutique European investment and financial markets consulting firm operating in Frankfurt and Berlin, Germany and has been involved in over 250 IPO’s, financings, bond issues, dual listings, and corporate finance transactions as well as corresponding road shows and awareness campaigns. 

 

RAD and WFL share prices today: